Global Pneumonia Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pneumonia Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Consumables
1.2.3 Analyzers
1.3 Market by Application
1.3.1 Global Pneumonia Testing Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Medical Center
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Pneumonia Testing Market Size (2017-2028)
2.2 Pneumonia Testing Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Pneumonia Testing Market Size by Region (2017-2022)
2.4 Global Pneumonia Testing Market Size Forecast by Region (2023-2028)
2.5 Global Top Pneumonia Testing Countries Ranking by Market Size
3 Pneumonia Testing Competitive by Company
3.1 Global Pneumonia Testing Revenue by Players
3.1.1 Global Pneumonia Testing Revenue by Players (2017-2022)
3.1.2 Global Pneumonia Testing Market Share by Players (2017-2022)
3.2 Global Pneumonia Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Pneumonia Testing Revenue
3.4 Global Pneumonia Testing Market Concentration Ratio
3.4.1 Global Pneumonia Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pneumonia Testing Revenue in 2021
3.5 Global Pneumonia Testing Key Players Head office and Area Served
3.6 Key Players Pneumonia Testing Product Solution and Service
3.7 Date of Enter into Pneumonia Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Pneumonia Testing Breakdown Data by Type
4.1 Global Pneumonia Testing Historic Revenue by Type (2017-2022)
4.2 Global Pneumonia Testing Forecasted Revenue by Type (2023-2028)
5 Global Pneumonia Testing Breakdown Data by Application
5.1 Global Pneumonia Testing Historic Market Size by Application (2017-2022)
5.2 Global Pneumonia Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pneumonia Testing Revenue by Company (2020-2022)
6.2 North America Pneumonia Testing Revenue by Type (2017-2028)
6.3 North America Pneumonia Testing Revenue by Application (2017-2028)
6.4 North America Pneumonia Testing Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Pneumonia Testing Revenue by Company (2020-2022)
7.2 Europe Pneumonia Testing Revenue by Type (2017-2028)
7.3 Europe Pneumonia Testing Revenue by Application (2017-2028)
7.4 Europe Pneumonia Testing Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Pneumonia Testing Revenue by Company (2020-2022)
8.2 Asia Pacific Pneumonia Testing Revenue by Type (2017-2028)
8.3 Asia Pacific Pneumonia Testing Revenue by Application (2017-2028)
8.4 Asia Pacific Pneumonia Testing Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Pneumonia Testing Revenue by Company (2020-2022)
9.2 Latin America Pneumonia Testing Revenue by Type (2017-2028)
9.3 Latin America Pneumonia Testing Revenue by Application (2017-2028)
9.4 Latin America Pneumonia Testing Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pneumonia Testing Revenue by Company (2020-2022)
10.2 Middle East and Africa Pneumonia Testing Revenue by Type (2017-2028)
10.3 Middle East and Africa Pneumonia Testing Revenue by Application (2017-2028)
10.4 Middle East and Africa Pneumonia Testing Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Abbott Molecular
11.1.1 Abbott Molecular Company Details
11.1.2 Abbott Molecular Business Overview
11.1.3 Abbott Molecular Pneumonia Testing Products and Services
11.1.4 Abbott Molecular Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.1.5 Abbott Molecular Pneumonia Testing SWOT Analysis
11.1.6 Abbott Molecular Recent Developments
11.2 Fast-track diagnostics
11.2.1 Fast-track diagnostics Company Details
11.2.2 Fast-track diagnostics Business Overview
11.2.3 Fast-track diagnostics Pneumonia Testing Products and Services
11.2.4 Fast-track diagnostics Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.2.5 Fast-track diagnostics Pneumonia Testing SWOT Analysis
11.2.6 Fast-track diagnostics Recent Developments
11.3 Becton, Dickenson and Company (BD)
11.3.1 Becton, Dickenson and Company (BD) Company Details
11.3.2 Becton, Dickenson and Company (BD) Business Overview
11.3.3 Becton, Dickenson and Company (BD) Pneumonia Testing Products and Services
11.3.4 Becton, Dickenson and Company (BD) Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.3.5 Becton, Dickenson and Company (BD) Pneumonia Testing SWOT Analysis
11.3.6 Becton, Dickenson and Company (BD) Recent Developments
11.4 Roche Molecular Diagnostics
11.4.1 Roche Molecular Diagnostics Company Details
11.4.2 Roche Molecular Diagnostics Business Overview
11.4.3 Roche Molecular Diagnostics Pneumonia Testing Products and Services
11.4.4 Roche Molecular Diagnostics Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.4.5 Roche Molecular Diagnostics Pneumonia Testing SWOT Analysis
11.4.6 Roche Molecular Diagnostics Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Pneumonia Testing Products and Services
11.5.4 Thermo Fisher Scientific Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.5.5 Thermo Fisher Scientific Pneumonia Testing SWOT Analysis
11.5.6 Thermo Fisher Scientific Recent Developments
11.6 AdvanDx
11.6.1 AdvanDx Company Details
11.6.2 AdvanDx Business Overview
11.6.3 AdvanDx Pneumonia Testing Products and Services
11.6.4 AdvanDx Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.6.5 AdvanDx Pneumonia Testing SWOT Analysis
11.6.6 AdvanDx Recent Developments
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Pneumonia Testing Products and Services
11.7.4 Abbott Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.7.5 Abbott Pneumonia Testing SWOT Analysis
11.7.6 Abbott Recent Developments
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Details
11.8.2 Beckman Coulter Business Overview
11.8.3 Beckman Coulter Pneumonia Testing Products and Services
11.8.4 Beckman Coulter Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.8.5 Beckman Coulter Pneumonia Testing SWOT Analysis
11.8.6 Beckman Coulter Recent Developments
11.9 Bio-Rad
11.9.1 Bio-Rad Company Details
11.9.2 Bio-Rad Business Overview
11.9.3 Bio-Rad Pneumonia Testing Products and Services
11.9.4 Bio-Rad Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.9.5 Bio-Rad Pneumonia Testing SWOT Analysis
11.9.6 Bio-Rad Recent Developments
11.10 Cepheid
11.10.1 Cepheid Company Details
11.10.2 Cepheid Business Overview
11.10.3 Cepheid Pneumonia Testing Products and Services
11.10.4 Cepheid Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.10.5 Cepheid Pneumonia Testing SWOT Analysis
11.10.6 Cepheid Recent Developments
11.11 Concile
11.11.1 Concile Company Details
11.11.2 Concile Business Overview
11.11.3 Concile Pneumonia Testing Products and Services
11.11.4 Concile Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.11.5 Concile Recent Developments
11.12 Diamedix
11.12.1 Diamedix Company Details
11.12.2 Diamedix Business Overview
11.12.3 Diamedix Pneumonia Testing Products and Services
11.12.4 Diamedix Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.12.5 Diamedix Recent Developments
11.13 DiaSorin
11.13.1 DiaSorin Company Details
11.13.2 DiaSorin Business Overview
11.13.3 DiaSorin Pneumonia Testing Products and Services
11.13.4 DiaSorin Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.13.5 DiaSorin Recent Developments
11.14 Eiken Chemical
11.14.1 Eiken Chemical Company Details
11.14.2 Eiken Chemical Business Overview
11.14.3 Eiken Chemical Pneumonia Testing Products and Services
11.14.4 Eiken Chemical Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022)
11.14.5 Eiken Chemical Recent Developments
12 Pneumonia Testing Market Dynamics
12.1 Pneumonia Testing Market Trends
12.2 Pneumonia Testing Market Drivers
12.3 Pneumonia Testing Market Challenges
12.4 Pneumonia Testing Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of TablesTable 1. Global Pneumonia Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Consumables
Table 3. Key Players of Analyzers
Table 4. Global Pneumonia Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Pneumonia Testing Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Pneumonia Testing Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Pneumonia Testing Revenue Market Share by Region (2017-2022)
Table 8. Global Pneumonia Testing Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Pneumonia Testing Market Share by Players (2017-2022)
Table 10. Global Top Pneumonia Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Testing as of 2021)
Table 11. Ranking of Global Top Pneumonia Testing Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Pneumonia Testing Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Pneumonia Testing Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Pneumonia Testing Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Pneumonia Testing Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Pneumonia Testing Revenue Market Share by Type (2017-2022)
Table 19. Global Pneumonia Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Pneumonia Testing Revenue Market Share by Type (2023-2028)
Table 21. Global Pneumonia Testing Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Pneumonia Testing Revenue Market Share by Application (2017-2022)
Table 23. Global Pneumonia Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Pneumonia Testing Revenue Market Share by Application (2023-2028)
Table 25. North America Pneumonia Testing Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Pneumonia Testing Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Pneumonia Testing Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Pneumonia Testing Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Pneumonia Testing Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Pneumonia Testing Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Pneumonia Testing Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Pneumonia Testing Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Pneumonia Testing Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Pneumonia Testing Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Pneumonia Testing Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Pneumonia Testing Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Pneumonia Testing Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Pneumonia Testing Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Pneumonia Testing Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Pneumonia Testing Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Pneumonia Testing Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Pneumonia Testing Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Pneumonia Testing Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Pneumonia Testing Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Pneumonia Testing Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Pneumonia Testing Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Pneumonia Testing Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Pneumonia Testing Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Pneumonia Testing Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Pneumonia Testing Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Pneumonia Testing Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Pneumonia Testing Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Pneumonia Testing Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Pneumonia Testing Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Pneumonia Testing Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Pneumonia Testing Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Pneumonia Testing Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Pneumonia Testing Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Pneumonia Testing Revenue by Country (2023-2028) & (US$ Million)
Table 60. Abbott Molecular Company Details
Table 61. Abbott Molecular Business Overview
Table 62. Abbott Molecular Pneumonia Testing Product and Services
Table 63. Abbott Molecular Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 64. Abbott Molecular Pneumonia Testing SWOT Analysis
Table 65. Abbott Molecular Recent Developments
Table 66. Fast-track diagnostics Company Details
Table 67. Fast-track diagnostics Business Overview
Table 68. Fast-track diagnostics Pneumonia Testing Product and Services
Table 69. Fast-track diagnostics Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 70. Fast-track diagnostics Pneumonia Testing SWOT Analysis
Table 71. Fast-track diagnostics Recent Developments
Table 72. Becton, Dickenson and Company (BD) Company Details
Table 73. Becton, Dickenson and Company (BD) Business Overview
Table 74. Becton, Dickenson and Company (BD) Pneumonia Testing Product and Services
Table 75. Becton, Dickenson and Company (BD) Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 76. Becton, Dickenson and Company (BD) Pneumonia Testing SWOT Analysis
Table 77. Becton, Dickenson and Company (BD) Recent Developments
Table 78. Roche Molecular Diagnostics Company Details
Table 79. Roche Molecular Diagnostics Business Overview
Table 80. Roche Molecular Diagnostics Pneumonia Testing Product and Services
Table 81. Roche Molecular Diagnostics Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 82. Roche Molecular Diagnostics Pneumonia Testing SWOT Analysis
Table 83. Roche Molecular Diagnostics Recent Developments
Table 84. Thermo Fisher Scientific Company Details
Table 85. Thermo Fisher Scientific Business Overview
Table 86. Thermo Fisher Scientific Pneumonia Testing Product and Services
Table 87. Thermo Fisher Scientific Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 88. Thermo Fisher Scientific Pneumonia Testing SWOT Analysis
Table 89. Thermo Fisher Scientific Recent Developments
Table 90. AdvanDx Company Details
Table 91. AdvanDx Business Overview
Table 92. AdvanDx Pneumonia Testing Product and Services
Table 93. AdvanDx Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 94. AdvanDx Pneumonia Testing SWOT Analysis
Table 95. AdvanDx Recent Developments
Table 96. Abbott Company Details
Table 97. Abbott Business Overview
Table 98. Abbott Pneumonia Testing Product and Services
Table 99. Abbott Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 100. Abbott Pneumonia Testing SWOT Analysis
Table 101. Abbott Recent Developments
Table 102. Beckman Coulter Company Details
Table 103. Beckman Coulter Business Overview
Table 104. Beckman Coulter Pneumonia Testing Product and Services
Table 105. Beckman Coulter Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 106. Beckman Coulter Pneumonia Testing SWOT Analysis
Table 107. Beckman Coulter Recent Developments
Table 108. Bio-Rad Company Details
Table 109. Bio-Rad Business Overview
Table 110. Bio-Rad Pneumonia Testing Product and Services
Table 111. Bio-Rad Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 112. Bio-Rad Pneumonia Testing SWOT Analysis
Table 113. Bio-Rad Recent Developments
Table 114. Cepheid Company Details
Table 115. Cepheid Business Overview
Table 116. Cepheid Pneumonia Testing Product and Services
Table 117. Cepheid Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 118. Cepheid Pneumonia Testing SWOT Analysis
Table 119. Cepheid Recent Developments
Table 120. Concile Company Details
Table 121. Concile Business Overview
Table 122. Concile Pneumonia Testing Product and Services
Table 123. Concile Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 124. Concile Recent Developments
Table 125. Diamedix Company Details
Table 126. Diamedix Business Overview
Table 127. Diamedix Pneumonia Testing Product and Services
Table 128. Diamedix Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 129. Diamedix Recent Developments
Table 130. DiaSorin Company Details
Table 131. DiaSorin Business Overview
Table 132. DiaSorin Pneumonia Testing Product and Services
Table 133. DiaSorin Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 134. DiaSorin Recent Developments
Table 135. Eiken Chemical Company Details
Table 136. Eiken Chemical Business Overview
Table 137. Eiken Chemical Pneumonia Testing Product and Services
Table 138. Eiken Chemical Pneumonia Testing Revenue in Pneumonia Testing Business (2017-2022) & (US$ Million)
Table 139. Eiken Chemical Recent Developments
Table 140. Pneumonia Testing Market Trends
Table 141. Pneumonia Testing Market Drivers
Table 142. Pneumonia Testing Market Challenges
Table 143. Pneumonia Testing Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Pneumonia Testing Sales Market Share by Type: 2021 VS 2028
Figure 2. Consumables Features
Figure 3. Analyzers Features
Figure 4. Global Pneumonia Testing Sales Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Medical Center Case Studies
Figure 8. Other Case Studies
Figure 9. Pneumonia Testing Report Years Considered
Figure 10. Global Pneumonia Testing Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Pneumonia Testing Market Size 2017-2028 (US$ Million)
Figure 12. Global Pneumonia Testing Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Pneumonia Testing Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Pneumonia Testing Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Pneumonia Testing Market Share by Players in 2021
Figure 16. Global Top Pneumonia Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Testing as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Pneumonia Testing Revenue in 2021
Figure 18. North America Pneumonia Testing Revenue Market Share by Company in 2021
Figure 19. North America Pneumonia Testing Revenue Market Share by Type (2017-2028)
Figure 20. North America Pneumonia Testing Revenue Market Share by Application (2017-2028)
Figure 21. North America Pneumonia Testing Revenue Share by Country (2017-2028)
Figure 22. U.S. Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Pneumonia Testing Revenue Market Share by Company in 2021
Figure 25. Europe Pneumonia Testing Revenue Market Share by Type (2017-2028)
Figure 26. Europe Pneumonia Testing Revenue Market Share by Application (2017-2028)
Figure 27. Europe Pneumonia Testing Revenue Share by Country (2017-2028)
Figure 28. Germany Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 29. France Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Pneumonia Testing Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Pneumonia Testing Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Pneumonia Testing Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Pneumonia Testing Revenue Share by Region (2017-2028)
Figure 37. China Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 40. India Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 46. Philippines Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 47. Vietnam Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Pneumonia Testing Revenue Market Share by Company in 2021
Figure 49. Latin America Pneumonia Testing Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Pneumonia Testing Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Pneumonia Testing Revenue Share by Country (2017-2028)
Figure 52. Mexico Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Pneumonia Testing Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Pneumonia Testing Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Pneumonia Testing Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Pneumonia Testing Revenue Share by Country (2017-2028)
Figure 59. Turkey Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 61. UAE Pneumonia Testing Revenue (2017-2028) & (US$ Million)
Figure 62. Abbott Molecular Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 63. Fast-track diagnostics Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 64. Becton, Dickenson and Company (BD) Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 65. Roche Molecular Diagnostics Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 66. Thermo Fisher Scientific Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 67. AdvanDx Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 68. Abbott Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 69. Beckman Coulter Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 70. Bio-Rad Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 71. Cepheid Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 72. Concile Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 73. Diamedix Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 74. DiaSorin Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 75. Eiken Chemical Revenue Growth Rate in Pneumonia Testing Business (2017-2022)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed